End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.64 USD | -1.52% | -2.92% | +18.82% |
06-18 | Alvotech, Advanz Pharma Collaborate to Supply, Commercialize Proposed Biosimilar to Eylea in Europe | MT |
06-18 | Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.82% | 3.77B | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech Secures $965 Million Term Loan Facility